Bartlett James M, Siola Patricia L
James M. Bartlett, Pharm.D., is Clinical Pharmacist, Kenmore Mercy Hospital, Kenmore, NY; at the time of writing, he was a clinical pharmacy consultant for Trinity Medical of Western New York, Buffalo. Patricia L. Siola, B.S.Pharm., M.B.A., Ph.D., FASHP, FACHE, is Director of Pharmacy, Catholic Health System-Northtowns, Buffalo.
Am J Health Syst Pharm. 2014 Jun 1;71(11):943-9. doi: 10.2146/ajhp130602.
The implementation of an antimicrobial stewardship program (ASP) at a small community hospital affiliated with an accountable care organization (ACO) is described, including a report on first-year program outcomes.
With no infectious diseases (ID)-trained pharmacists on staff, a 155-bed hospital formed an ASP by restructuring its clinical pharmacy services. One full-time pharmacist led the program; nine full- or part-time pharmacists-none of whom had residency training-shared ASP responsibilities on a weekly rotation. Under a contract with a private medical group, an ID physician reviewed cases with ASP pharmacists for up to two hours each weekday. ASP interventions and tracking and reporting of outcomes were done primarily by pharmacists. Monitoring of pharmacy purchases in the first year of the program indicated an annualized 26% decrease in overall antimicrobial expenditures from prior-year spending, with a nearly 18% decrease in defined daily doses per 1000 patient-days. Total first-year direct cost savings attributed to the ASP were estimated at $145,353. Pharmacist-initiated conversions of patients from i.v. to oral antimicrobial therapy increased by 688% (p < 0.0001). Overall, the rate of ID physician acceptance of ASP-recommended interventions (mainly streamlining of therapy, limiting the duration of therapy to a specific stop date, and discontinuation of nonindicated drugs) was 74%.
An ASP was implemented at a small ACO-affiliated community hospital by a team of pharmacists without specialized ID training. During the first year of the program, antimicrobial expenditures were reduced and there was a significant increase in pharmacist-initiated i.v.-to-oral conversions.
描述在一家隶属于责任医疗组织(ACO)的小型社区医院实施抗菌药物管理计划(ASP)的情况,包括该计划第一年的成果报告。
由于医院员工中没有接受过传染病(ID)培训的药剂师,一家拥有155张床位的医院通过重组其临床药学服务形成了一个ASP。一名全职药剂师领导该计划;九名全职或兼职药剂师(均未接受过住院医师培训)每周轮流承担ASP职责。根据与一家私人医疗集团的合同,一名ID医生每个工作日与ASP药剂师一起审查病例长达两小时。ASP干预措施以及结果的跟踪和报告主要由药剂师完成。该计划第一年对药房采购的监测表明,抗菌药物总支出较上一年度年化下降了26%,每1000个患者日的限定日剂量下降了近18%。归因于ASP的第一年直接成本节省估计为145,353美元。药剂师发起的将患者从静脉注射抗菌治疗转换为口服抗菌治疗的次数增加了688%(p<0.0001)。总体而言,ID医生接受ASP推荐干预措施(主要是简化治疗、将治疗持续时间限制在特定停药日期以及停用非必要药物)的比例为74%。
一家隶属于ACO的小型社区医院由一组未接受过专门ID培训的药剂师实施了ASP。在该计划的第一年,抗菌药物支出减少,药剂师发起的从静脉注射到口服的转换显著增加。